Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Beveridge

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The International Journal of Biological Markers|June 15, 1999
Review of clinical studies of CA 27.29 in breast cancer managementR A Beveridge
Journal of Addictive Diseases|January 1, 1994
Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologistsR H Schwartz, R A Beveridge
Obstetrics and Gynecology Clinics of North America|December 1, 1994
Management of recurrent breast cancerN J Robert, R A Beveridge
Oncology (Williston Park, N.Y.)|April 1, 1988
Adjuvant chemotherapy of breast cancer--the Consensus Development Conference revisitedM D Abeloff, R A Beveridge
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Evaluation: continued need for randomized trialsR A Beveridge, D H Regan
Journal of Immunological Methods|January 1, 1979
Identification and quantitation of B and T cells by cytofluorographic analysisR A Beveridge, B S Super, P B Chretien
Archives of Dermatology|September 1, 1988
An unusual fungal infection in an immunocompromised oncology patient. Cutaneous alternariosisJ M Junkins, R A Beveridge, K J Friedman
Archives of Dermatology|April 1, 1989
Observations and proposed mechanism of N,N',N''-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentationT D Horn, R A Beveridge, M J Egorin, et al.
Annals of Clinical and Laboratory Science|November 1, 1989
CA-549: immunohistochemistry and serum levels in breast carcinoma and other neoplasmsM S Shurbaji, R A Beveridge, D W Chan, et al.
American Journal of Clinical Pathology|April 1, 1994
Breast cancer marker Ca549. A multicenter studyD W Chan, R A Beveridge, A Bhargava, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The International Journal of Biological Markers|June 15, 1999
Review of clinical studies of CA 27.29 in breast cancer managementR A Beveridge
Journal of Addictive Diseases|January 1, 1994
Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologistsR H Schwartz, R A Beveridge
Obstetrics and Gynecology Clinics of North America|December 1, 1994
Management of recurrent breast cancerN J Robert, R A Beveridge
Oncology (Williston Park, N.Y.)|April 1, 1988
Adjuvant chemotherapy of breast cancer--the Consensus Development Conference revisitedM D Abeloff, R A Beveridge
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Evaluation: continued need for randomized trialsR A Beveridge, D H Regan
Journal of Immunological Methods|January 1, 1979
Identification and quantitation of B and T cells by cytofluorographic analysisR A Beveridge, B S Super, P B Chretien
Archives of Dermatology|September 1, 1988
An unusual fungal infection in an immunocompromised oncology patient. Cutaneous alternariosisJ M Junkins, R A Beveridge, K J Friedman
Archives of Dermatology|April 1, 1989
Observations and proposed mechanism of N,N',N''-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentationT D Horn, R A Beveridge, M J Egorin, et al.
Annals of Clinical and Laboratory Science|November 1, 1989
CA-549: immunohistochemistry and serum levels in breast carcinoma and other neoplasmsM S Shurbaji, R A Beveridge, D W Chan, et al.
American Journal of Clinical Pathology|April 1, 1994
Breast cancer marker Ca549. A multicenter studyD W Chan, R A Beveridge, A Bhargava, et al.
Pageof 3